Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.66 |
| ▸ | AKT1 | P31749 | 3/20 | 0.57 |
| ▸ | PLAU | P00749 | 1/20 | 0.57 |
| ▸ | PLAUR | Q03405 | 1/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.57 |
| ▸ | AKT2 | P31751 | 1/20 | 0.57 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.55 |
| ▸ | DPP4 | P27487 | 2/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | XIAP | P98170 | 1/20 | 0.54 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27154397 | 0.89 | HSD17B10 (0.71) | HDAC8AKT1PLAUPLAUROPRD1 | |
| SCHEMBL11226904 | 0.89 | HSD17B10 (0.71) | HDAC8AKT1PLAUPLAUROPRD1 | |
| SCHEMBL7214004 | 0.89 | HSD17B10 (0.71) | HDAC8AKT1PLAUPLAUROPRD1 | |
| Hydrochloric Acid SCHEMBL6898277 | 0.88 | HDAC8 (0.69) | HDAC8AKT1PLAUPLAUROPRD1 | |
| Hydrochloric Acid SCHEMBL27547045 | 0.88 | HDAC8 (0.69) | HDAC8AKT1PLAUPLAUROPRD1 | |
| SCHEMBL1619160 | 0.87 | HDAC8 (0.69) | HDAC8AKT1PLAUPLAUROPRD1 | |
| SCHEMBL1040335 | 0.87 | HDAC8 (0.69) | HDAC8AKT1PLAUPLAUROPRD1 | |
| SCHEMBL368452 | 0.87 | HDAC8 (0.69) | HDAC8AKT1PLAUPLAUROPRD1 | |
| SCHEMBL1039399 | 0.86 | HDAC8 (0.68) | HDAC8AKT1PLAUPLAUROPRD1 | |
| Bromide SCHEMBL8750830 | 0.86 | HDAC8 (0.68) | HDAC8AKT1PLAUPLAUROPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1134213-B1 | Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides | PFIZER (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-0832065-B1 | SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS | PFIZER (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1134213-A2 | Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides | PFIZER INC. (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6277877-B1 | GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS | PFIZER, INC. | 2001-08-21 | — | — | US | disclosed |
| US-6107329-A | HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS | PFIZER, INC. (US) | 2000-08-22 | — | — | US | disclosed |
| WO-1996039384-A1 | SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS | PFIZER, INC. (US) | 1996-12-12 | — | — | WO | disclosed |